Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Janiel Cragun
Associate Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
Obstetrics and Gynecology
Overview
Research
More
Collaboration
(9)
Setsuko Chambers
Mutual work: 3 Publications﹒4 Grants
Collaboration Details
Mitzi Miranda
Mutual work: 4 Grants
Collaboration Details
Hina Arif Tiwari
Mutual work: 4 Publications
Collaboration Details
Carolyn Lane
Mutual work: 1 Grant
Collaboration Details
Guang Yao
Mutual work: 1 Publication
Collaboration Details
Page 1 of 2
Previous page
Next page
Grants
(7)
A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Nab-Paclitaxel Monotherapy in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tu
Active
·
2023
·
$0 / $560.9K
·
External
Co-Investigator (COI)
ovarian cancer,
combination therapy,
platinum-resistant,
peritoneal cancer,
fallopian-tube cancer
Multicenter, Open-label, Phase 2 Study of Carboplatin Plus Mirvetuximab Soravtansine Followed by Mirvetuximab Soravtansine Continuation in Folate
Active
·
2023
·
$0 / $419.4K
·
External
Co-Investigator (COI)
chemotherapy,
antibody-drug conjugate,
ovarian cancer,
clinical trial,
folate receptor
A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec followed by Platinum-doublet Chemotherapy and Bevacizumab Compared with Platinum-doublet Chemotherapy and Bevacizumab in Women
Active
·
2023
·
$0 / $270.2K
·
External
Co-Investigator (COI)
clinical trials,
cancer treatment,
immunotherapy,
chemotherapy,
women's health
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of Upifitamab Rilsodotin (XMT-1536) as Post-Platnum Maintenance Therapy for Participants with Recurrent, Platinum-Sensitive
Active
·
2023
·
$0 / $217.6K
·
External
Co-Investigator (COI)
cancer therapy,
clinical trial,
pharmacology,
immunotherapy,
drug development
ARIEL4 (Assessment of Rucaparib In Ovarian CancEr TriaL): A Phase 3 Multicenter, Randomized Study of Rucaparib versus Chemotherapy in Patients with Relapsed, BRCA-Mutant, High-Grade Epithelial Ovar...
2016
·
$152.3K
·
External
Principal Investigator (PI)
oncology,
clinical trials,
chemotherapy,
brca mutations,
ovarian cancer
Page 1 of 2
Previous page
Next page
Publications
(38)
Recent
Antiandrogen Flutamide-Induced Restoration of miR-449 Expression Mitigates Molecular Markers Associated with Ovarian Cancer Risk
2024
ovarian cancer,
mir-449,
antiandrogen,
molecular markers,
flutamide
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study
2022
Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without or Mutations
2019
chemotherapy,
hypersensitivity,
ovarian cancer,
genetic mutations,
peritoneal cancer
Incidence of Hypersensitivity Reactions to Carboplatin in Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer with or without BRCA1 or BRCA2 Mutations
2018
drug hypersensitivity,
cancer treatment,
genetic mutations,
ovarian cancer,
brca mutations
The utility of patient reported data in a gynecologic oncology clinic
2018
An Interdisciplinary program to prevent postoperative pneumonia: An Evidenced-Based Project.
2018
Simple Patient Care Instructions Translate Best: Safety Guidelines for Physician Use of Google Translate
2017
patient care,
language translation,
physician guidelines,
safety,
google translate
MRI of ovarian torsion: Correlation of imaging features with the presence of perifollicular hemorrhage and ovarian viability
2016
mri imaging,
ovarian torsion,
perifollicular hemorrhage,
ovarian viability,
correlation analysis
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma ARIEL2 Part 1) an international, multicentre, open-label, phase 2 trial
2016
Assessment of the Role of Intraoperative Frozen Section in Guiding Surgical Staging for Endometrial Cancer
2016
cancer,
surgery,
pathology,
endometrial,
diagnostic